Improving clozapine utilization will require continued advocacy, drug sponsor interest, and FDA support to address REMS issues.
Jonathan G LeungMegan EhretRaymond C LoveRobert O CotesPublished in: Expert review of clinical pharmacology (2023)
Keyphrases